{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:07:32Z","timestamp":1788829652063,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Special Fund for high-level Talents in the medical and Health industry of Jinan City"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05463-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:15:04Z","timestamp":1782195304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based integration develops a novel lysosome-related prognostic signature associated with prognosis and immune infiltration landscape in acute myeloid leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"Linna","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5463_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jfma.2024.04.002","volume":"123","author":"L Yang","year":"2024","unstructured":"Yang L, Xu Q, Li J. Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia. J Formos Med Assoc. 2024;123:992\u20131003. https:\/\/doi.org\/10.1016\/j.jfma.2024.04.002.","journal-title":"J Formos Med Assoc"},{"key":"5463_CR2","first-page":"5308","volume":"14","author":"H Ding","year":"2022","unstructured":"Ding H, Feng Y, Xu J, Lin Z, Huang J, Wang F, et al. A novel immune prognostic model of non-M3 acute myeloid leukemia. Am J Transl Res. 2022;14:5308\u201325.","journal-title":"Am J Transl Res"},{"key":"5463_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie D, Helgason GV, Copland M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat Rev Cancer. 2020;20:158\u201373. https:\/\/doi.org\/10.1038\/s41568-019-0230-9.","journal-title":"Nat Rev Cancer"},{"key":"5463_CR4","doi-asserted-by":"publisher","unstructured":"Stanchina M, Soong D, Zheng-Lin B, Watts JM, Taylor J. Advances in acute myeloid leukemia: recently approved therapies and drugs in development. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12113225.","DOI":"10.3390\/cancers12113225"},{"key":"5463_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3760\/cma.j.cn121090-20250307-00119","volume":"46","author":"L Chen","year":"2025","unstructured":"Chen L, Chen SJ. [The cure for acute promyelocytic leukemia and China\u2019s contributions]. Zhonghua Xue Ye Xue Za Zhi. 2025;46:377. https:\/\/doi.org\/10.3760\/cma.j.cn121090-20250307-00119.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"5463_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H, Estey EH, Amadori S, Appelbaum FR, B\u00fcchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453\u201374. https:\/\/doi.org\/10.1182\/blood-2009-07-235358.","journal-title":"Blood"},{"key":"5463_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1182\/blood-2015-07-604546","volume":"127","author":"JJ Cornelissen","year":"2016","unstructured":"Cornelissen JJ, Blaise D. Hematopoietic stem cell transplantation for patients with AML in first complete remission. Blood. 2016;127:62\u201370. https:\/\/doi.org\/10.1182\/blood-2015-07-604546.","journal-title":"Blood"},{"key":"5463_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.20517\/cdr.2021.122","volume":"5","author":"L Cuesta-Casanovas","year":"2022","unstructured":"Cuesta-Casanovas L, Delgado-Mart\u00ednez J, Cornet-Masana JM, Carb\u00f3 JM, Cl\u00e9ment-Demange L, Risue\u00f1o RM. Lysosome-mediated chemoresistance in acute myeloid leukemia. Cancer Drug Resist. 2022;5:233\u201344. https:\/\/doi.org\/10.20517\/cdr.2021.122.","journal-title":"Cancer Drug Resist"},{"key":"5463_CR9","doi-asserted-by":"publisher","first-page":"1384633","DOI":"10.3389\/fimmu.2024.1384633","volume":"15","author":"P Wan","year":"2024","unstructured":"Wan P, Zhong L, Yu L, Shen C, Shao X, Chen S, et al. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy. Front Immunol. 2024;15:1384633. https:\/\/doi.org\/10.3389\/fimmu.2024.1384633.","journal-title":"Front Immunol"},{"key":"5463_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.trecan.2020.05.004","volume":"6","author":"B Wang","year":"2020","unstructured":"Wang B, Kohli J, Demaria M. Senescent Cells in Cancer Therapy: Friends or Foes? Trends Cancer. 2020;6:838\u201357. https:\/\/doi.org\/10.1016\/j.trecan.2020.05.004.","journal-title":"Trends Cancer"},{"key":"5463_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1172\/jci64180","volume":"123","author":"MA Sukhai","year":"2013","unstructured":"Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, et al. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors. J Clin Investig. 2013;123:315\u201328. https:\/\/doi.org\/10.1172\/jci64180.","journal-title":"J Clin Investig"},{"key":"5463_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/leu.2008.103","volume":"22","author":"B Chapuy","year":"2008","unstructured":"Chapuy B, Koch R, Radunski U, Corsham S, Cheong N, Inagaki N, et al. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia. 2008;22:1576\u201386. https:\/\/doi.org\/10.1038\/leu.2008.103.","journal-title":"Leukemia"},{"key":"5463_CR13","doi-asserted-by":"publisher","first-page":"31761","DOI":"10.1074\/jbc.M113.514091","volume":"288","author":"T Yamagishi","year":"2013","unstructured":"Yamagishi T, Sahni S, Sharp DM, Arvind A, Jansson PJ, Richardson DR. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J Biol Chem. 2013;288:31761\u201371. https:\/\/doi.org\/10.1074\/jbc.M113.514091.","journal-title":"J Biol Chem"},{"key":"5463_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/gcc.20500","volume":"47","author":"DL Stirewalt","year":"2008","unstructured":"Stirewalt DL, Meshinchi S, Kopecky KJ, Fan W, Pogosova-Agadjanyan EL, Engel JH, et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer. 2008;47:8\u201320. https:\/\/doi.org\/10.1002\/gcc.20500.","journal-title":"Genes Chromosomes Cancer"},{"key":"5463_CR15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1200\/jco.2012.44.3184","volume":"31","author":"Z Li","year":"2013","unstructured":"Li Z, Herold T, He C, Valk PJM, Chen P, Jurinovic V, et al. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol. 2013;31:1172\u201381. https:\/\/doi.org\/10.1200\/jco.2012.44.3184.","journal-title":"J Clin Oncol"},{"key":"5463_CR16","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1182\/blood-2008-02-134411","volume":"112","author":"KH Metzeler","year":"2008","unstructured":"Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K, Braess J, Sauerland M-C, et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood. 2008;112:4193\u2013201. https:\/\/doi.org\/10.1182\/blood-2008-02-134411.","journal-title":"Blood"},{"key":"5463_CR17","doi-asserted-by":"publisher","first-page":"1169256","DOI":"10.3389\/fimmu.2023.1169256","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Wang Q, Lu J, Zhao B, Geng Y, Wu X, et al. Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma. Front Immunol. 2023;14:1169256. https:\/\/doi.org\/10.3389\/fimmu.2023.1169256.","journal-title":"Front Immunol"},{"key":"5463_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"5463_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics"},{"key":"5463_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. . GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 2013. 14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7"},{"key":"5463_CR21","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326:1614\u201321. https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"JAMA"},{"key":"5463_CR22","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.","journal-title":"eLife"},{"key":"5463_CR23","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/jci129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Investig. 2020;130:1552\u201364. https:\/\/doi.org\/10.1172\/jci129204.","journal-title":"J Clin Investig"},{"key":"5463_CR24","doi-asserted-by":"publisher","first-page":"e25643","DOI":"10.1016\/j.heliyon.2024.e25643","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, Sun K, Yang H, Zou D, Xia L, Lu K, et al. Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer. Heliyon. 2024;10:e25643. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25643.","journal-title":"Heliyon"},{"key":"5463_CR25","doi-asserted-by":"publisher","first-page":"642494","DOI":"10.3389\/fcell.2021.642494","volume":"9","author":"ER Machado","year":"2021","unstructured":"Machado ER, Annunziata I, van de Vlekkert D, Grosveld GC, d\u2019Azzo A. Lysosomes and Cancer Progression: A Malignant Liaison. Front cell Dev biology. 2021;9:642494. https:\/\/doi.org\/10.3389\/fcell.2021.642494.","journal-title":"Front cell Dev biology"},{"key":"5463_CR26","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1007\/s00018-021-03988-3","volume":"78","author":"KK Mahapatra","year":"2021","unstructured":"Mahapatra KK, Mishra SR, Behera BP, Patil S, Gewirtz DA, Bhutia SK. The lysosome as an imperative regulator of autophagy and cell death. Cell Mol Life Sci. 2021;78:7435\u201349. https:\/\/doi.org\/10.1007\/s00018-021-03988-3.","journal-title":"Cell Mol Life Sci"},{"key":"5463_CR27","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.1039\/d1fo00987g","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhou X, Hong T, Qi W, Zhang K, Geng F, et al. Lysosome-mediated mitochondrial apoptosis induced by tea polysaccharides promotes colon cancer cell death. Food Funct. 2021;12:10524\u201337. https:\/\/doi.org\/10.1039\/d1fo00987g.","journal-title":"Food Funct"},{"key":"5463_CR28","doi-asserted-by":"publisher","first-page":"1149995","DOI":"10.3389\/fgene.2023.1149995","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu Y, Huang C, Wu J, Shao Y, Wang Z, et al. Subtypes analysis and prognostic model construction based on lysosome-related genes in colon adenocarcinoma. Front Genet. 2023;14:1149995. https:\/\/doi.org\/10.3389\/fgene.2023.1149995.","journal-title":"Front Genet"},{"key":"5463_CR29","doi-asserted-by":"publisher","first-page":"1135365","DOI":"10.3389\/fgene.2023.1135365","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yang F, Zhang W, Zhou Y, Duan D, Liu S, et al. A novel lysosome-related gene signature coupled with gleason score for prognosis prediction in prostate cancer. Front Genet. 2023;14:1135365. https:\/\/doi.org\/10.3389\/fgene.2023.1135365.","journal-title":"Front Genet"},{"key":"5463_CR30","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3389\/fphar.2018.01345","volume":"9","author":"K Schmit","year":"2018","unstructured":"Schmit K, Michiels C. TMEM Proteins in Cancer: A Review. Front Pharmacol. 2018;9:1345. https:\/\/doi.org\/10.3389\/fphar.2018.01345.","journal-title":"Front Pharmacol"},{"key":"5463_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajhg.2012.05.002","volume":"91","author":"F Foulquier","year":"2012","unstructured":"Foulquier F, Amyere M, Jaeken J, Zeevaert R, Schollen E, Race V, et al. TMEM165 deficiency causes a congenital disorder of glycosylation. Am J Hum Genet. 2012;91:15\u201326. https:\/\/doi.org\/10.1016\/j.ajhg.2012.05.002.","journal-title":"Am J Hum Genet"},{"key":"5463_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yexmp.2012.03.013","volume":"93","author":"X Zheng","year":"2012","unstructured":"Zheng X, Chang F, Zhang X, Rothman VL, Tuszynski GP. G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker. Exp Mol Pathol. 2012;93:111\u20135. https:\/\/doi.org\/10.1016\/j.yexmp.2012.03.013.","journal-title":"Exp Mol Pathol"},{"key":"5463_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jop.13376","volume":"52","author":"T Zhang","year":"2023","unstructured":"Zhang T, Liu G, Zhang J, Chen S, Deng Z, Xie M. GPRASP1 is a candidate anti-oncogene and correlates with immune microenvironment and immunotherapeutic efficiency in head and neck cancer. J oral Pathol medicine: official publication Int Association Oral Pathologists Am Acad Oral Pathol. 2023;52:232\u201344. https:\/\/doi.org\/10.1111\/jop.13376.","journal-title":"J oral Pathol medicine: official publication Int Association Oral Pathologists Am Acad Oral Pathol"},{"key":"5463_CR34","doi-asserted-by":"publisher","first-page":"154374","DOI":"10.1016\/j.prp.2023.154374","volume":"243","author":"J Du","year":"2023","unstructured":"Du J, Chen Y, Liu G, Zeng Q, Zhou N, Du D. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer. Pathol - Res Pract. 2023;243:154374. https:\/\/doi.org\/10.1016\/j.prp.2023.154374.","journal-title":"Pathol - Res Pract"},{"key":"5463_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/atvbaha.108.179283","volume":"30","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010;30:139\u201343. https:\/\/doi.org\/10.1161\/atvbaha.108.179283.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5463_CR36","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1172\/jci57559","volume":"121","author":"AJ Murphy","year":"2011","unstructured":"Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, Kuo C-L, et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest. 2011;121:4138\u201349. https:\/\/doi.org\/10.1172\/jci57559.","journal-title":"J Clin Invest"},{"key":"5463_CR37","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1016\/j.celrep.2020.02.056","volume":"30","author":"M Viaud","year":"2020","unstructured":"Viaud M, Abdel-Wahab O, Gall J, Ivanov S, Guinamard R, Sore S, et al. ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms. Cell Rep. 2020;30:3397\u2013e34105. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.056.","journal-title":"Cell Rep"},{"key":"5463_CR38","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00442.2020","volume":"320","author":"AF Eaton","year":"2021","unstructured":"Eaton AF, Merkulova M, Brown D. The H(+)-ATPase (V-ATPase): from proton pump to signaling complex in health and disease. Am J Physiol Cell Physiol. 2021;320:C392\u2013414. https:\/\/doi.org\/10.1152\/ajpcell.00442.2020.","journal-title":"Am J Physiol Cell Physiol"},{"key":"5463_CR39","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.ebiom.2019.11.042","volume":"51","author":"J Couto-Vieira","year":"2020","unstructured":"Couto-Vieira J, Nicolau-Neto P, Costa EP, Figueira FF, Sim\u00e3o TDA, Okorokova-Fa\u00e7anha AL, et al. Multi-cancer V-ATPase molecular signatures: A distinctive balance of subunit C isoforms in esophageal carcinoma. EBioMedicine. 2020;51:102581. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.042.","journal-title":"EBioMedicine"},{"key":"5463_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41419-020-02904-0","volume":"11","author":"X Sun","year":"2020","unstructured":"Sun X, Shu Y, Yan P, Huang H, Gao R, Xu M, et al. Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib. Cell Death Dis. 2020;11:702.","journal-title":"Cell Death Dis"},{"key":"5463_CR41","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie S-J, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94:1099\u2013142. https:\/\/doi.org\/10.1152\/physrev.00034.2013.","journal-title":"Physiol Rev"},{"key":"5463_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12967-014-0339-2","volume":"12","author":"IM Larr\u00e1yoz","year":"2014","unstructured":"Larr\u00e1yoz IM, Mart\u00ednez-Herrero S, Garc\u00eda-Sanmart\u00edn J, Ochoa-Callejero L, Mart\u00ednez A. Adrenomedullin and tumour microenvironment. J Transl Med. 2014;12:339. https:\/\/doi.org\/10.1186\/s12967-014-0339-2.","journal-title":"J Transl Med"},{"key":"5463_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3024360","volume":"2022","author":"R Wang","year":"2022","unstructured":"Wang R, Li M, Bai Y, Jiao Y, Qi X. CALCRL Gene is a Suitable Prognostic Factor in AML\/ETO(+) AML Patients. J Oncol. 2022;2022:1\u20137. https:\/\/doi.org\/10.1155\/2022\/3024360.","journal-title":"J Oncol"},{"key":"5463_CR44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41467-020-20717-9","volume":"12","author":"C Larrue","year":"2021","unstructured":"Larrue C, Guiraud N, Mouchel PL, Dubois M, Farge T, Gotan\u00e8gre M, et al. Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Nat Commun. 2021;12:422. https:\/\/doi.org\/10.1038\/s41467-020-20717-9.","journal-title":"Nat Commun"},{"key":"5463_CR45","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1038\/s41598-018-28070-0","volume":"8","author":"V Russo","year":"2018","unstructured":"Russo V, Klein T, Lim DJ, Solis N, Machado Y, Hiroyasu S, et al. Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction. Sci Rep. 2018;8:9690. https:\/\/doi.org\/10.1038\/s41598-018-28070-0.","journal-title":"Sci Rep"},{"key":"5463_CR46","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/ijc.25135","volume":"127","author":"D D\u2019Eliseo","year":"2010","unstructured":"D\u2019Eliseo D, Pisu P, Romano C, Tubaro A, De Nunzio C, Morrone S, et al. Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion. Int J Cancer. 2010;127:1283\u201394. https:\/\/doi.org\/10.1002\/ijc.25135.","journal-title":"Int J Cancer"},{"key":"5463_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-016-0302-6","volume":"35","author":"D D\u2019Eliseo","year":"2016","unstructured":"D\u2019Eliseo D, Di Rocco G, Loria R, Soddu S, Santoni A, Velotti F. Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells. J Exp Clin Canc Res. 2016;35:24. https:\/\/doi.org\/10.1186\/s13046-016-0302-6.","journal-title":"J Exp Clin Canc Res"},{"key":"5463_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10841-2","author":"Z Lu","year":"2024","unstructured":"Lu Z, Huang X, Shen Q, Chen E, Feng Y, Granzyme B, Promotes Proliferation. Migration and EMT Process in Gastric Cancer. Biochem Genet. 2024. https:\/\/doi.org\/10.1007\/s10528-024-10841-2.","journal-title":"Biochem Genet"},{"key":"5463_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/icb.2008.42","volume":"86","author":"AO Speak","year":"2008","unstructured":"Speak AO, Cerundolo V, Platt FM. CD1d presentation of glycolipids. Immunol Cell Biol. 2008;86:588\u201397. https:\/\/doi.org\/10.1038\/icb.2008.42.","journal-title":"Immunol Cell Biol"},{"key":"5463_CR50","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/sj.leu.2402943","volume":"17","author":"LS Metelitsa","year":"2003","unstructured":"Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia. 2003;17:1068\u201377. https:\/\/doi.org\/10.1038\/sj.leu.2402943.","journal-title":"Leukemia"},{"key":"5463_CR51","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.leukres.2013.12.015","volume":"38","author":"A Bojarska-Junak","year":"2014","unstructured":"Bojarska-Junak A, Hus I, Chocholska S, Tomczak W, Wo\u015b J, Czubak P, et al. CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis. Leuk Res. 2014;38:435\u201342. https:\/\/doi.org\/10.1016\/j.leukres.2013.12.015.","journal-title":"Leuk Res"},{"key":"5463_CR52","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3892\/ol.2014.2208","volume":"8","author":"W Guo","year":"2014","unstructured":"Guo W, Dong A, Xing C, Lin X, Pan X, Lin Y, et al. CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia. Oncol Lett. 2014;8:825\u201330. https:\/\/doi.org\/10.3892\/ol.2014.2208.","journal-title":"Oncol Lett"},{"key":"5463_CR53","first-page":"173","volume":"21","author":"L Ciszak","year":"2009","unstructured":"Ciszak L, Kosmaczewska A, Werynska B, Szteblich A, Jankowska R, Frydecka I. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer. Oncol Rep. 2009;21:173\u201384.","journal-title":"Oncol Rep"},{"key":"5463_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4196\/kjpp.2018.22.1.43","volume":"22","author":"Y-N Ha","year":"2018","unstructured":"Ha Y-N, Sung HY, Yang S-D, Chae YJ, Ju W, Ahn J-H. Epigenetic modification of \u03b1-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer. Korean J Physiol Pharmacol: Off J Korean Physiol Soc Korean Soc Pharmacol. 2018;22:43.","journal-title":"Korean J Physiol Pharmacol: Off J Korean Physiol Soc Korean Soc Pharmacol"},{"key":"5463_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/cbin.11727","volume":"46","author":"M Jafari","year":"2022","unstructured":"Jafari M, Rahimi N, Jami M, Hashemzadeh Chaleshtori M, Elahian F, Mirzaei SA. Silencing of \u03b1-N-acetylgalactosaminidase in the gastric cancer cells amplified cell death and attenuated migration, while the multidrug resistance remained unchanged. Cell Biol Int. 2022;46:255\u201364. https:\/\/doi.org\/10.1002\/cbin.11727.","journal-title":"Cell Biol Int"},{"key":"5463_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3199589","volume":"2022","author":"F Cheng","year":"2022","unstructured":"Cheng F, Li Q, Wang J, Wang L, Li W, Zeng F. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia. Dis Markers. 2022;2022:1\u201322. https:\/\/doi.org\/10.1155\/2022\/3199589.","journal-title":"Dis Markers"},{"key":"5463_CR57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13046-021-02007-4","volume":"40","author":"Z Li","year":"2021","unstructured":"Li Z, Wang F, Tian X, Long J, Ling B, Zhang W, et al. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML. J experimental Clin cancer research: CR. 2021;40:210. https:\/\/doi.org\/10.1186\/s13046-021-02007-4.","journal-title":"J experimental Clin cancer research: CR"},{"key":"5463_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.htct.2023.11.007","volume":"46","author":"MFL Carvalho","year":"2024","unstructured":"Carvalho MFL, De Almeida BO, Bueno MLP, Vicari HP, Lima K, Rego EM, et al. Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents. Hematol Transfus Cell Ther. 2024;46:273\u201382. https:\/\/doi.org\/10.1016\/j.htct.2023.11.007.","journal-title":"Hematol Transfus Cell Ther"},{"key":"5463_CR59","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3389\/fimmu.2020.01218","volume":"11","author":"S Zuo","year":"2020","unstructured":"Zuo S, Wei M, Wang S, Dong J, Wei J. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Front Immunol. 2020;11:1218. https:\/\/doi.org\/10.3389\/fimmu.2020.01218.","journal-title":"Front Immunol"},{"key":"5463_CR60","doi-asserted-by":"publisher","first-page":"e00270","DOI":"10.1128\/jvi.00270-23","volume":"97","author":"LY Yim","year":"2023","unstructured":"Yim LY, Lam KS, Luk T-Y, Mo Y, Lu X, Wang J, et al. Transforming Growth Factor \u03b2 Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4(+) T Cells. J Virol. 2023;97:e00270\u201323. https:\/\/doi.org\/10.1128\/jvi.00270-23.","journal-title":"J Virol"},{"key":"5463_CR61","doi-asserted-by":"publisher","first-page":"104943","DOI":"10.1016\/j.oraloncology.2020.104943","volume":"110","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li B, Peng Y, Wu F, Li Q, Lin Z, et al. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Oral Oncol. 2020;110:104943. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104943.","journal-title":"Oral Oncol"},{"key":"5463_CR62","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.7150\/jca.35901","volume":"10","author":"SC Zhang","year":"2019","unstructured":"Zhang SC, Hu ZQ, Long JH, Zhu GM, Wang Y, Jia Y, et al. Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer. J Cancer. 2019;10:6175\u201384. https:\/\/doi.org\/10.7150\/jca.35901.","journal-title":"J Cancer"},{"key":"5463_CR63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000444942","volume":"43","author":"M Ammendola","year":"2016","unstructured":"Ammendola M, Sacco R, Sammarco G, Luposella M, Patruno R, Gadaleta CD, et al. Mast Cell-Targeted Strategies in Cancer Therapy. Transfus Med Hemoth. 2016;43:109\u201313. https:\/\/doi.org\/10.1159\/000444942.","journal-title":"Transfus Med Hemoth"},{"key":"5463_CR64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/16078454.2021.1889158","volume":"26","author":"M Jia","year":"2021","unstructured":"Jia M, Zhang H, Wang L, Zhao L, Fan S, Xi Y. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia. Hematology. 2021;26:284\u201394. https:\/\/doi.org\/10.1080\/16078454.2021.1889158.","journal-title":"Hematology"},{"key":"5463_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1189\/jlb.1212621","volume":"94","author":"AM Intlekofer","year":"2013","unstructured":"Intlekofer AM, Thompson CB. At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. J Leukoc Biol. 2013;94:25\u201339. https:\/\/doi.org\/10.1189\/jlb.1212621.","journal-title":"J Leukoc Biol"},{"key":"5463_CR66","doi-asserted-by":"crossref","unstructured":"Wang H, Han X, Xu J. Lysosome as the Black Hole for Checkpoint Molecules. In: Xu J, editor. Adv Exp Med Biol. 2020. 325\u201346.","DOI":"10.1007\/978-981-15-3266-5_14"},{"key":"5463_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","volume":"24","author":"B Zhitomirsky","year":"2016","unstructured":"Zhitomirsky B, Assaraf YG. Lysosomes as mediators of drug resistance in cancer. Drug Resist updates: reviews commentaries Antimicrob anticancer Chemother. 2016;24:23\u201333. https:\/\/doi.org\/10.1016\/j.drup.2015.11.004.","journal-title":"Drug Resist updates: reviews commentaries Antimicrob anticancer Chemother"},{"key":"5463_CR68","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12185-019-02701-2","volume":"110","author":"Y Mizutani","year":"2019","unstructured":"Mizutani Y, Inase A, Maimaitili Y, Miyata Y, Kitao A, Matsumoto H, et al. An mTORC1\/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells. Int J Hematol. 2019;110:490\u20139. https:\/\/doi.org\/10.1007\/s12185-019-02701-2.","journal-title":"Int J Hematol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05463-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05463-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05463-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:19:24Z","timestamp":1788826764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05463-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5463"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05463-6","relation":{"references":[{"id-type":"doi","id":"10.1186\/1471-2105-14-7","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1308"}}